Resmed (RSMDF) Receivables - Net (2010 - 2026)

Resmed has reported Receivables - Net for 17 years, with the latest figure at $998.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 10.03% year-over-year to $998.8 million; the trailing twelve-month figure through Mar 2026 stood at $998.8 million (up 10.03% YoY), and the FY2025 full-year result was $939.5 million, up 12.21% from the prior year.
• Receivables - Net for Q1 2026 stood at $998.8 million, up from $985.6 million in the prior quarter.
• The five-year high for Receivables - Net was $998.8 million in Q1 2026, with the low at $508.6 million in Q1 2022.
• Historically, Receivables - Net has averaged $777.5 million across 5 years, with a median of $779.3 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables - Net retreated 6.24% — and 2023, when it soared 34.94%.
• Resmed's Receivables - Net stood at $672.3 million in 2022, then rose by 8.55% to $729.7 million in 2023, then grew by 17.84% to $859.9 million in 2024, then rose by 14.62% to $985.6 million in 2025, then rose by 1.34% to $998.8 million in 2026.
• The last three Receivables - Net figures came in at $998.8 million (Q1 2026), $985.6 million (Q4 2025), and $907.3 million (Q3 2025), per Business Quant data.